The Manufacturers Life Insurance Company grew its holdings in shares of Humana Inc (NYSE:HUM) by 9.8% in the fourth quarter, HoldingsChannel.com reports. The fund owned 172,384 shares of the insurance provider’s stock after purchasing an additional 15,425 shares during the quarter. The Manufacturers Life Insurance Company ‘s holdings in Humana were worth $42,764,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Several other hedge funds have also modified their holdings of the company. Janus Henderson Group PLC grew its position in shares of Humana by 74.1% during the 3rd quarter. Janus Henderson Group PLC now owns 2,729,248 shares of the insurance provider’s stock valued at $664,921,000 after acquiring an additional 1,161,661 shares during the period. Wells Fargo & Company MN boosted its holdings in Humana by 11.4% in the 4th quarter. Wells Fargo & Company MN now owns 1,842,029 shares of the insurance provider’s stock worth $456,951,000 after buying an additional 188,711 shares during the period. Ameriprise Financial Inc. boosted its holdings in Humana by 10.8% in the 3rd quarter. Ameriprise Financial Inc. now owns 1,465,119 shares of the insurance provider’s stock worth $356,960,000 after buying an additional 142,706 shares during the period. Acadian Asset Management LLC boosted its holdings in Humana by 3.0% in the 4th quarter. Acadian Asset Management LLC now owns 1,043,303 shares of the insurance provider’s stock worth $258,809,000 after buying an additional 30,812 shares during the period. Finally, Capital International Investors boosted its holdings in Humana by 8.8% in the 3rd quarter. Capital International Investors now owns 760,500 shares of the insurance provider’s stock worth $185,281,000 after buying an additional 61,500 shares during the period. 97.68% of the stock is owned by hedge funds and other institutional investors.
In other Humana news, SVP Brian P. Leclaire sold 1,679 shares of the company’s stock in a transaction dated Thursday, December 21st. The shares were sold at an average price of $245.97, for a total value of $412,983.63. Following the transaction, the senior vice president now directly owns 9,888 shares in the company, valued at approximately $2,432,151.36. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, SVP Jody L. Bilney sold 7,054 shares of the stock in a transaction that occurred on Monday, December 18th. The shares were sold at an average price of $247.89, for a total transaction of $1,748,616.06. Following the transaction, the senior vice president now owns 11,704 shares in the company, valued at $2,901,304.56. The disclosure for this sale can be found here. Insiders sold a total of 10,115 shares of company stock worth $2,501,627 over the last 90 days. Insiders own 0.80% of the company’s stock.
Humana Inc (NYSE HUM) opened at $269.00 on Tuesday. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.85 and a quick ratio of 1.61. The company has a market cap of $37,037.08, a PE ratio of 16.13, a price-to-earnings-growth ratio of 1.45 and a beta of 0.93. Humana Inc has a one year low of $203.36 and a one year high of $293.35.
Humana (NYSE:HUM) last issued its earnings results on Wednesday, February 7th. The insurance provider reported $2.06 EPS for the quarter, topping the Zacks’ consensus estimate of $2.00 by $0.06. The business had revenue of $13.19 billion for the quarter, compared to the consensus estimate of $13.14 billion. Humana had a net margin of 4.55% and a return on equity of 16.13%. The company’s revenue for the quarter was up 2.4% compared to the same quarter last year. During the same period in the prior year, the firm earned $2.34 EPS. sell-side analysts anticipate that Humana Inc will post 13.86 earnings per share for the current fiscal year.
Humana announced that its board has approved a share buyback plan on Thursday, December 14th that permits the company to buyback $3.00 billion in shares. This buyback authorization permits the insurance provider to reacquire shares of its stock through open market purchases. Shares buyback plans are usually a sign that the company’s leadership believes its stock is undervalued.
The business also recently announced a quarterly dividend, which will be paid on Friday, April 27th. Shareholders of record on Friday, March 30th will be paid a $0.50 dividend. This is an increase from Humana’s previous quarterly dividend of $0.40. This represents a $2.00 dividend on an annualized basis and a yield of 0.74%. The ex-dividend date of this dividend is Wednesday, March 28th. Humana’s dividend payout ratio is currently 9.59%.
Several analysts have commented on the stock. Zacks Investment Research upgraded shares of Humana from a “hold” rating to a “buy” rating and set a $294.00 price target on the stock in a research note on Monday, February 12th. JPMorgan Chase & Co. boosted their price target on shares of Humana from $253.00 to $271.00 and gave the stock a “neutral” rating in a research note on Monday, February 12th. Deutsche Bank boosted their price target on shares of Humana from $259.00 to $270.00 and gave the stock a “hold” rating in a research note on Friday, February 9th. Oppenheimer boosted their price target on shares of Humana from $275.00 to $305.00 and gave the stock an “outperform” rating in a research note on Thursday, February 8th. Finally, Leerink Swann boosted their price target on shares of Humana from $280.00 to $300.00 and gave the stock an “outperform” rating in a research note on Thursday, February 8th. Seven analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company’s stock. The company currently has an average rating of “Buy” and an average price target of $270.47.
Humana Inc is a health and well-being company. The Company’s segments include Retail, Group and Specialty, Healthcare Services and Individual Commercial. The Retail segment consists of Medicare benefits, as well as individual commercial fully insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.
Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc (NYSE:HUM).
Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.